Virbac S.A.
VIRP
Rang in aandelen
#4665
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Aandeelprijs
$388.56
Marktkapitalisatie
$3.26B
Verandering (1 dag)
-5.05%
Verandering (1 jaar)
-5.77%
Land
FR
Handel Virbac S.A. (VIRP)
Categorie
Healthcare
Winst voor Virbac S.A. (VIRP)
Winst in Jun 2026 TTM: $265.58M
Volgens de meest recente financiële verslagen van Virbac S.A. bedraagt de huidige winst van het bedrijf $265.58M. In 2023 behaalde het bedrijf een winst van $192.52M, een stijging ten opzichte van de winst van 2022, die $189.27M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Virbac S.A. van 2002 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $265.58M | 22.55% |
| 2024 | $216.71M | 12.56% |
| 2023 | $192.52M | 1.72% |
| 2022 | $189.27M | 10.86% |
| 2021 | $170.73M | -19.12% |
| 2020 | $211.09M | 141.63% |
| 2019 | $87.36M | 83.84% |
| 2018 | $47.52M | -3.41% |
| 2017 | $49.20M | -11.53% |
| 2016 | $55.61M | 250.68% |
| 2015 | $15.86M | -86.85% |
| 2014 | $120.60M | -7.42% |
| 2013 | $130.28M | 3.46% |
| 2012 | $125.92M | 16.49% |
| 2011 | $108.09M | -6.13% |
| 2010 | $115.16M | 42.50% |
| 2009 | $80.81M | 15.08% |
| 2008 | $70.22M | -0.38% |
| 2007 | $70.49M | 41.66% |
| 2006 | $49.76M | 37.75% |
| 2005 | $36.13M | 5.39% |
| 2004 | $34.28M | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $33.60B | 12,550.12% |
US
|
|
| $17.74B | 6,578.71% |
US
|
|
| $8.70B | 3,175.53% |
US
|
|
| $5.95B | 2,139.67% |
US
|
|
| $21.39B | 7,953.57% |
CH
|
